John Shannon
President chez XERIS BIOPHARMA HOLDINGS, INC.
Fortune : 1 M $ au 30/06/2024
Profil
Mr. John P.
Shannon, Jr., is a President & Chief Operating Officer at Xeris Biopharma Holdings, Inc. Mr. Shannon was previously employed as a President, Chief Operating Officer & Director by Xeris Pharmaceuticals, Inc., a Chief Executive Officer & Director by Catheter Connections, Inc., a Chief Commercial Officer by Durata Therapeutics, Inc., a Vice President & General Manager by Baxter BioScience Corp., a General Manager-US Biopharmaceuticals by Baxter Healthcare Corp., a Senior Director by Viatris Holdings LLC, a Head-Sales Operations, Marketing & Strategic by Bock Pharmacal Co., and a Vice President-Marketing by Caremark LLC.
He received his undergraduate degree from Western Illinois University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/04/2024 | 553 691 ( 0,37% ) | 1 M $ | 30/06/2024 |
Postes actifs de John Shannon
| Sociétés | Poste | Début |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | President | 05/10/2021 |
Anciens postes connus de John Shannon
| Sociétés | Poste | Fin |
|---|---|---|
Catheter Connections, Inc.
 Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Directeur Général | 01/01/2016 |
| DURATA THERAPEUTICS INC | Corporate Officer/Principal | 01/11/2014 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Corporate Officer/Principal | 01/01/2012 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/01/2011 |
| Viatris Holdings LLC | Corporate Officer/Principal | 01/01/2001 |
Formation de John Shannon
| Western Illinois University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Health Technology |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
| Caremark LLC | |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
| Viatris Holdings LLC | |
Bock Pharmacal Co.
 Bock Pharmacal Co. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Bock Pharmacal Co. is a wholesale pharmaceutical packaging and distribution company. The company is based in St. Louis, MO. Bock Pharmacal was acquired by Sanofi on July 17, 1996. | Commercial Services |
